skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: Science Citation Index Expanded (Web of Science) remover tipo de recurso: Book Chapters remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Additive Effects of TRAIL and Paclitaxel on Cancer Cells: Implications for Advances in Cancer Therapy
Additive Effects of TRAIL and Paclitaxel on Cancer Cells: Implications for Advances in Cancer Therapy
Material Type:
Capítulo de Livro 		Adicionar ao Meu Espaço

Additive Effects of TRAIL and Paclitaxel on Cancer Cells: Implications for Advances in Cancer Therapy

Odoux, Christine ; Albers, Andreas

Trail, 2004, Vol.67, p.385-407 [Periódico revisado por pares]

United States: Elsevier Science & Technology

Texto completo disponível

Citações Citado por
2
Case History: Vemurafenib, a Potent, Selective, and First-in-Class Inhibitor of Mutant BRAF for the Treatment of Metastatic Melanoma
Case History: Vemurafenib, a Potent, Selective, and First-in-Class Inhibitor of Mutant BRAF for the Treatment of Metastatic Melanoma
Material Type:
Capítulo de Livro 		Adicionar ao Meu Espaço

Case History: Vemurafenib, a Potent, Selective, and First-in-Class Inhibitor of Mutant BRAF for the Treatment of Metastatic Melanoma

Bollag, Gideon ; Ibrahim, Prabha ; Zhang, Chao ; Zhang, Jiazhong

Annual Reports in Medicinal Chemistry, 2013, Vol.48, p.435-449 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.